arrow
S

Silvia Papa

Sapienza University of Rome
H指数:22
被引数:1,672

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The added value of echocardiography in pulmonary arterial hypertension risk assessment an artificial intelligence machine learning–derived analysis of the ULTRA RIGHT VALUE registry

超声心动图在肺动脉高压风险评估中的附加价值:一项基于人工智能机器学习的ULTRA RIGHT VALUE注册研究分析

2026-09-170
OAAI
Multicenter invasive validation of the Venous Excess Ultrasound Score (VExUS) in patients referred for pulmonary hypertension

多中心侵入性验证在转诊肺动脉高压患者中的静脉过量超声评分(VExUS)

Chest
IF8.6
2026-08-290
PRE
The pleiotropic effects of sotatercept

sotatercept的多种效应

2025-12-200
PRE
ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of reveal risk score

ASPYRE-1研究:一项意大利多中心前瞻性研究,关于肺动脉高压的死亡模式及REVEAL风险评分的验证

2025-11-290
PRE
Early SGLT2i Therapy Facilitates In-Hospital ARNI Introduction Improving 6-Month Systolic Function in Patients with HFrEF

早期SGLT2i疗法有助于促进住院期间ARNI的引入,改善HFrEF患者6个月时的收缩功能

2025-10-060
OA
Early in-hospital use of SGLT2i in heart failure patients with ischemic etiology

缺血性病因心力衰竭患者早期院内使用SGLT2i

2025-05-150
OA
Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus

中危肺动脉高压患者治疗的证据空白: 专家共识

2024-12-012
PRE
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension
2024-10-012
PRE
The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database
2023-04-018
OAAI